APA (7th ed.) Citation

Borer, J. S., Swedberg, K., Komajda, M., Ford, I., Tavazzi, L., Boehm, M., . . . Wu, Y. (2015). BETA BLOCKER DOSAGE AND USE OVER TIME IN THE SYSTOLIC HEART FAILURE TREATMENT WITH THE IF INHIBITOR IVABRADINE TRIAL (SHIFT) STUDY. Journal of the American College of Cardiology, 65(10), A872. https://doi.org/10.1016/S0735-1097(15)60872-5

Chicago Style (17th ed.) Citation

Borer, Jeffrey S., Karl Swedberg, Michel Komajda, Ian Ford, Luigi Tavazzi, Michael Boehm, Fabienne Dominjon, Juan Maya, and Yuna Wu. "BETA BLOCKER DOSAGE AND USE OVER TIME IN THE SYSTOLIC HEART FAILURE TREATMENT WITH THE IF INHIBITOR IVABRADINE TRIAL (SHIFT) STUDY." Journal of the American College of Cardiology 65, no. 10 (2015): A872. https://doi.org/10.1016/S0735-1097(15)60872-5.

MLA (9th ed.) Citation

Borer, Jeffrey S., et al. "BETA BLOCKER DOSAGE AND USE OVER TIME IN THE SYSTOLIC HEART FAILURE TREATMENT WITH THE IF INHIBITOR IVABRADINE TRIAL (SHIFT) STUDY." Journal of the American College of Cardiology, vol. 65, no. 10, 2015, p. A872, https://doi.org/10.1016/S0735-1097(15)60872-5.